ORTEXORTEX News
Tracking AMP? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AM
Earnings PreviewAMP

BofA Downgrades Sour the Mood Before Ameriprise's October Print

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 25 Oct 2026, 04:01

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

AMP reports third-quarter results on October 28, and the pre-earnings analyst picture has turned decidedly more cautious just days before the release.

The most significant shift came on October 19, when BofA Securities downgraded Ameriprise from Buy to Underperform and cut its price target from $570 to $445, a move that puts the firm well below the current $492 price. Morgan Stanley, already carrying an Underweight, trimmed its target to $483 from $489 on October 9. BMO Capital also lowered its target to $520 from $560 earlier this month. The outlier is Evercore ISI, which nudged its target up to $632 while holding an In-Line rating. The overall consensus remains technically a buy, with a mean target of around $555, but the direction of travel from the most active voices this month is clearly downward.

The debate centres on two distinct parts of the business. The bull case rests on the wealth management engine: roughly 10,600 advisors, nearly $1.2 trillion in assets under management, and a capital return programme that channels about 80% of operating earnings back to shareholders. Fee-based advisory accounts provide a relatively stable revenue base, and EPS has a strong track record of coming in ahead of estimates, ranking in the 79th percentile for surprise. The bear case is less about the core franchise and more about the margins around it. Brokerage cash balances fell roughly 3% quarter-on-quarter to $36.9 billion, missing earlier expectations, while the asset management segment has seen deposit growth decelerate as withdrawals pick up. The retirement and protection business also faces headwinds from legacy insurance partner outflows and adverse claims experience.

Positioning heading into the print is calm rather than charged. Short interest is a modest 2.9% of the free float, roughly 7% lower than a month ago, and the borrow market is extremely loose, with availability at over 7,000%, meaning shares are easy to borrow and there is no squeeze pressure of any kind. The cost to borrow has risen about 30% over the past week to 0.58%, but that remains an extremely low absolute rate. Options traders are similarly composed: the put/call ratio of 0.54 is almost exactly in line with its 20-day average, and the z-score is effectively zero. Nothing in the derivatives market suggests meaningful hedging demand ahead of Wednesday's numbers.

One data point worth noting is that retail attention has picked up. Wikipedia views for Ameriprise are running more than two standard deviations above their own 90-day average, the highest attention reading in recent months. That is a measure of public interest, not a revenue indicator, but it does suggest the print is on more people's radar than usual.

The October 28 report will test whether the core wealth management business can sustain its fee revenue trajectory at a time when the cash balances and asset management flows that underpin it are moving in the wrong direction, and whether management's capital return story is enough to offset the concerns that prompted BofA's rare outright downgrade.

Stocks in this article

See the live data behind this article on ORTEX.

Open AMP on ORTEX →

How this article was generated

Generated
25 Oct 2026, 04:14
Data as of
25 Oct 2026, 04:01
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.